Yu Yong

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$10,000.00
Insider Sells Quantity
14
Insider Sells Sum
$3.21M

Insider Activity of Yu Yong

According to the SEC Form 4 filings, Yu Yong, being in a position of

  1. VP, Clinical Trial Operations at Genelux Corporation,
    оver the last 12 months, has bought 2500 shares for $10,000, and sold 123384 shares for $1.49M,
    over all time since 2023-08-18, has bought 2500 shares for $10,000, and sold 197849 shares for $3.21M.

The largest purchase of all time was on 2024-05-29 and amounted to 2500 shares of Genelux Corporation for $10,000.

The largest sale of all time was on 2023-09-13 and amounted to 29800 shares of Genelux Corporation for $629,927.

Biography of Yu Yong

No biography is available at this moment.

2024-06-24SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
6,849
0.0185%
$2.12$14,520-3.51%
2024-05-29PurchaseGenelux Corporation
GNLX
VP, Clinical Trial Operations
2,500
0.0105%
$4.00$10,000-18.57%
2023-12-15SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
32,535
0.1265%
$13.16$428,180-69.89%
2023-12-07SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
36,800
0.1379%
$11.85$435,995-65.79%
2023-11-21SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
18,665
0.0713%
$10.26$191,555-56.98%
2023-11-20SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
14,594
0.0592%
$11.26$164,261-57.18%
2023-11-17SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
3,541
0.0148%
$13.04$46,170-61.1%
2023-10-24SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
5,200
0.0193%
$19.11$99,351-71.67%
2023-10-10SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
5,200
0.0184%
$22.01$114,462-72.2%
2023-09-26SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
5,200
0.021%
$23.56$122,528-71.39%
2023-09-20SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
6,000
0.0223%
$27.96$167,786-77.55%
2023-09-15SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
10,400
0.0385%
$21.89$227,630-69.57%
2023-09-13SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
29,800
0.1061%
$21.14$629,927-67.39%
2023-08-30SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
19,800
0.0751%
$24.70$489,060-67.44%
2023-08-18SaleGenelux Corporation
GNLX
VP, Clinical Trial Operations
3,265
0.0124%
$23.73$77,478-60.05%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.